• No results found

Molecular Biotechnology Program Uppsala University School of Engineering

N/A
N/A
Protected

Academic year: 2022

Share "Molecular Biotechnology Program Uppsala University School of Engineering"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Molecular Biotechnology Program

Uppsala University School of Engineering

UPTEC X 07 051 Date of issue 2007-08

Author

Jonas Wamstad

Title (English)

Development of vaccines aimed at controlling/down- regulating allergic reactions

Title (Swedish)

Abstract

This report summarizes the development of a protocol for purifying three new allergy vaccine candidates. Such a protocol has now successfully been developed and this protocol can be used to purify relatively large amounts of the vaccine from one single fermentor batch.

Keywords

Recombinant protein, cloning, expression vector, vaccine, immune system, Ion Metal Affinity Chromatography (IMAC), Size Exclusion Chromatography (SEC), fermentation, fermentor, IgE, allergy

Supervisors

Lars Hellman

Professor of Immunology

Scientific reviewer

Magnus Åbrink

Associate professor of Immunology Project name

Theravac Pharmaceuticals

Sponsors

Language

English

Security

ISSN 1401-2138 Classification

Supplementary bibliographical information Pages

26

Biology Education Centre Biomedical Center Husargatan 3 Uppsala Box 592 S-75124 Uppsala Tel +46 (0)18 4710000 Fax +46 (0)18 555217

References

Related documents

The expansion of the voltage-gated calcium channel alpha 1 subunit families (CACNA1) of L and N types was investigated by combining phylogenetic analyses (neighbour-joining and

In this degree project Sortase A from Staphylococcus aureus was explored and potential inhibitors were investigated by performing enzyme activity and bacterial binding assays. A

The characterized genes showed gradual improvement and divergence of functions, supporting the Innovation-Amplification-Divergence model of

Moreover, by applying a molecular clock, it is proposed that the Domestic cat lineage has experienced several expansions representing domestication and/or breeding

It showed large dynamic range, no measureable non-specific binding and high sensitivity (with linear range around 0.1 – 10 µg/ml depending on the proteins). The method

This combined with recent research showing biocompatibility with cells gives the spider silk a wider range of applications such as for biomedical applications. pastoris, with each

Escherichia coli, 23S rRNA, Post-transcriptional modification, In vitro, Peptidyl transferase centre, domain V, Methylation, Pseudouridine, Reverse

The fibrinolytic enzyme tissue type plasminogen activator (t-PA) is released by the vascular endothelium to limit the growth of blood clots and ultimately prevent the occurrence of